Shalini Jaggi
Shalini Jaggi publishes mostly in Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology and Surgery, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Gestational Diabetes Research and Management.
- World rank
- #7,200,795 of 7,710,434 ranked researchers
- Rank in India
- #254,117 of 280,097
- Works
- 78
- Citations
- 1.4k
- Citations per work
- 17.5
What does Shalini Jaggi research?
Shalini Jaggi's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4962.6%
- Medicine4962.6%
- Everything else2532.5%
- Life Sciences44.9%
- 1Endocrinology, Diabetes and Metabolism32% of their works
- 2Obstetrics and Gynecology10% of their works
- 3Surgery9% of their works
- 4Cardiology and Cardiovascular Medicine7% of their works
- 5Genetics5% of their works
- 6Physiology4% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Gestational Diabetes Research and Management
- Diabetes and associated disorders
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Metabolism, Diabetes, and Cancer
- Diet and metabolism studies
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Which keywords describe Shalini Jaggi's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Type 1 Diabetes, Metabolic Syndrome, Type 2 Diabetes, Continuous Glucose Monitoring and Hypoglycemia.
- Critical Care
- Low-Carbohydrate Diet
- AMP-Activated Protein Kinase
- Insulin Resistance
- Autoimmunity
- Glucose Control
- Cardiovascular Outcomes
- Hypoglycemia
- Type 2 Diabetes
- Type 1 Diabetes
- Insulin Therapy
- Glycemic Control
- Diabetes
- Metabolic Syndrome
- Continuous Glucose Monitoring
- Hyperglycemia
- Gestational Diabetes Mellitus
- Maternal Obesity
- Genetics
- Obesity
- Ketogenic Diet
- Metformin
- Infection Risk
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Glycemic Control423 topics
- Insulin Therapy423 topics
- Diabetes322 topics
- Type 1 Diabetes322 topics
- Metabolic Syndrome313 topics
- Type 2 Diabetes282 topics
- Continuous Glucose Monitoring221 topic
- Hypoglycemia221 topic
- Hyperglycemia202 topics
- Cardiovascular Outcomes141 topic
- Gestational Diabetes Mellitus141 topic
- Glucose Control141 topic
- Maternal Obesity141 topic
- Autoimmunity101 topic
- Genetics101 topic
- Insulin Resistance101 topic
- Obesity101 topic
- AMP-Activated Protein Kinase71 topic
- Ketogenic Diet71 topic
- Low-Carbohydrate Diet71 topic
- Metformin71 topic
- Critical Care61 topic
- Infection Risk61 topic
Where does Shalini Jaggi work?
Shalini Jaggi's main affiliation in the publication record is Diabetes Foundation, India.
How many publications and citations does Shalini Jaggi have?
OpenAlex counts 78 works and 1,364 citations for Shalini Jaggi, an h-index of 10, ranking #7,200,795 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shalini Jaggi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.